Charles River Laboratories International Beats Analyst Estimates on EPS

Just the facts, Fool.

Charles River Laboratories International(NYSE: CRL) reported earnings on Oct. 30. Here are the numbers you need to know.

The 10-second takeaway For the quarter ended Sep. 29 (Q3), Charles River Laboratories International met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue was unchanged and GAAP earnings per share grew significantly.

Margins increased across the board.

Revenue details Charles River Laboratories International chalked up revenue of $278.7 million. The 14 analysts polled by S&P Capital IQ expected to see a top line of $278.8 million on the same basis. GAAP reported sales were 0.4% higher than the prior-year quarter's $277.6 million.

EPS details EPS came in at $0.65. The 18 earnings estimates compiled by S&P Capital IQ predicted $0.62 per share. GAAP EPS of $0.46 for Q3 were 24% higher than the prior-year quarter's $0.37 per share.